Clinical Trial Update: Chemotherapy in Treating Children With Down Syndrome and Myeloproliferative Disorder, Acute Myelogenous Leukemia, or Myelodysplastic Syndrome [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating chemotherapy in children with Down syndrome and myelodysplastic/myeloproliferative disorders, acute myeloid leukemia, or mye…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• Myelodysplastic Myeloproliferative Neoplasms
• Myelodysplastic Syndromes

Snippet

Sponsor: Children's Oncology Group | Conditions: Leukemia, Myelodysplastic Syndromes | Phase 3 | Status: COMPLETED